Patients News | pharmaphorum

News

Mobile ADHD awareness game launches in Germany

Attention-deficit hyperactivity disorder (ADHD) in adults is not well understood and highly underdiagnosed, but the developers of a mobile game designed to raise awareness

News

Study finds abortion pills by telehealth safe and effective

As all eyes are on a landmark Supreme Court hearing on how patients in the US can access abortion pill mifepristone next month, a study has found that it is safe and effec

News

AbbVie’s 24-hour Parkinson’s therapy to roll out on NHS

Around 1,000 people with Parkinson’s disease will be able to access treatment with AbbVie’s Produodopa, the first therapy that can be delivered by a 24-hour subcutaneous i

News

Study backs safety of Gilead CAR-T as outpatient therapy

CAR-T therapies can achieve remarkable efficacy in the treatment of haematological cancers, but the risk of side effects means that the cell infusions are almost always ad

News

Innsena backs CancerX’s digital drive to improve access

Healthtech consultancy Innsena has committed funding and expertise to The White House’s CancerX initiative, launched last year to encourage the use of digital technologies

News

Exercise ‘may be better than drugs for depression’

Doctors should think twice before prescribing drug therapies when faced with someone battling depression, as exercise may be more effective, according to a new study.

Mobile ADHD awareness game launches in Germany

Study finds abortion pills by telehealth safe and effective

AbbVie’s 24-hour Parkinson’s therapy to roll out on NHS

Study backs safety of Gilead CAR-T as outpatient therapy

Innsena backs CancerX’s digital drive to improve access

Exercise ‘may be better than drugs for depression’

Netcompany claims NHS contract to help digitise screening

Discover a new era of healthcare panel engagement: Grounded ...

News

Editor's Picks